Atogepant: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Atogepant. Educational only — not medical advice.
Labeled uses
QULIPTA is indicated for the preventive treatment of migraine in adults.
Source: FDA labeling via NIH DailyMed (set 8c8ab8f4…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.